Diabetes drug abolishes characteristic signs of nicotine withdrawal in mice

A drug commonly used to treat Type II diabetes abolishes the characteristic signs of nicotine withdrawal in rats and mice, according to new research published in JNeurosci. The finding may offer an important new strategy in the battle to quit smoking.

Diabetes drug abolishes characteristic signs of nicotine withdrawal in mice

Smokers trying to quit face potent side effects from nicotine withdrawal, including cravings, increased appetite, restlessness, anxiety, irritability, and depression. Even though they may want to quit, many smokers continue to smoke simply because the experience is so unpleasant.

The diabetes drug, pioglitazone, targets a specific form of the peroxisome proliferator-activated receptors in the nucleus. This receptor, PPARγ, is found in areas of the brain involved in drug addiction.

Domi et al. demonstrated that direct injections of pioglitazone into the hippocampi of male mice reduced the signs of physical nicotine withdrawal, including paw tremors, chattering, and head shakes. Injecting pioglitazone into the amygdala of male mice ameliorated signs of anxiety associated with nicotine withdrawal.

Nicotine abusers face a 30% higher risk of developing Type II diabetes. The researchers suggest pioglitazone may help diabetic smokers quit by lessening the physical and emotional withdrawal symptoms while reducing insulin resistance.

Source:
Journal reference:

Domi, E., et al. (2019) Activation of PPARγ attenuates the expression of physical and affective nicotine withdrawal symptoms through mechanisms involving amygdala and hippocampus neurotransmission. Journal of Neuroscience. doi.org/10.1523/JNEUROSCI.1922-19.2019.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Society for Neuroscience. (2019, October 30). Diabetes drug abolishes characteristic signs of nicotine withdrawal in mice. News-Medical. Retrieved on January 25, 2021 from https://www.news-medical.net/news/20191030/Diabetes-drug-abolishes-characteristic-signs-of-nicotine-withdrawal-in-mice.aspx.

  • MLA

    Society for Neuroscience. "Diabetes drug abolishes characteristic signs of nicotine withdrawal in mice". News-Medical. 25 January 2021. <https://www.news-medical.net/news/20191030/Diabetes-drug-abolishes-characteristic-signs-of-nicotine-withdrawal-in-mice.aspx>.

  • Chicago

    Society for Neuroscience. "Diabetes drug abolishes characteristic signs of nicotine withdrawal in mice". News-Medical. https://www.news-medical.net/news/20191030/Diabetes-drug-abolishes-characteristic-signs-of-nicotine-withdrawal-in-mice.aspx. (accessed January 25, 2021).

  • Harvard

    Society for Neuroscience. 2019. Diabetes drug abolishes characteristic signs of nicotine withdrawal in mice. News-Medical, viewed 25 January 2021, https://www.news-medical.net/news/20191030/Diabetes-drug-abolishes-characteristic-signs-of-nicotine-withdrawal-in-mice.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
Functional connectome of fetal brain begins to take form in utero